Drug Eluting Stent Market in China - Industry Research Report 2015-2019

Drug eluting stent market forecasts in China

Drug eluting stent, also known as medicated coronary stent, is a tiny, expandable metal mesh tube that is covered with a pharmacologic agent (drug), which is used to prevent artery blockages in patients after angioplasty. The drug eluting stent market in China presents immense growth opportunities for vendors to expand their businesses during the forecast period, growing at a CAGR of close to 11%.

In recent years, the prevalence of cardiovascular diseases (CVDs) such as stroke, myocardial infarction, and CHDs have increased. The Chinese government is undertaking numerous measures to control and prevent CVDs, however, the mortality and morbidity rates are increasing continuously in the country. The high occurrence of obesity is also another leading cause of the rise in CVD cases in China. These factors will significantly contribute to the drug eluting stent market growth.

Competitive landscape and key vendors